View Cart (0 items)

Pharmaceutical

Pfizer wins patent-infringement case against Teva

Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt;
Read More

Addex Pharmaceuticals names new CEO

Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt;
Read More

NSF Reference Standards to be Traceable to U.S., European Pharmacopeial Standards

NSF International, which has 25 years of pharmaceutical expertise through its NSF Health Sciences Division, is launching NSF Reference Standards™, which will produce reference standards that are traceable to
Read More

Guatemalan Officials Seize 3,000 Barrels of Chemicals in Raid

A total of 3,000 barrels of chemicals used to produce synthetic drugs were seized and three suspects were arrested in a raid in Guatemala, Agencia EFE reported. The chemicals
Read More

Teva’s MS Drug Misses Study Goal

Teva Pharmaceutical Industries Ltd. said its experimental drug laquinimod, an oral treatment for multiple sclerosis, did not reduce patients'' annual relapse rate in a late-stage clinical trial, Forbes reported. Shares
Read More

Biogen, Acorda MS Drug Receives Conditional European OK

MarketWatch reports, Biogen Idec Inc. has received conditional approval of multiple sclerosis pill Fampyra in Europe, after a positive recommendation in May that followed an earlier rejection. The drug, developed
Read More

Pfizer Sues Apotex in US Over Generic Version of Lyrica

Pfizer Inc., the world’s largest drugmaker, accused Apotex Inc. in a lawsuit of infringing two U.S. patents for the nerve-pain drug Lyrica, reports Bloomberg. Apotex, based in Toronto, plans
Read More

GlaxoSmithKline to Pay 37 States $41 Million Over Faulty Drugs

British drugmaker GlaxoSmithKline PLC has reached a $40.75 million settlement with 37 states for selling potentially faulty and contaminated medicines produced at its former Puerto Rico factory during the last
Read More

USDA Takes Action Against Drug Manufacturer and Distributor

PRNewswire reports, the U.S. Food and Drug Administration announced that a consent decree of condemnation, forfeiture and permanent injunction has been filed against H&P Industries Inc., The Triad Group
Read More

Major Drug Companies Cut Vaccine Prices in Developing Countries

International Business Times reports, a group of major western pharmaceutical companies announced that they will significantly reduce the prices they charge for vaccines in the developing world. Merck & Co.,
Read More